awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35004750-259EF442-24A5-4D69-9595-8A4B8FF84E86
Q35004750-259EF442-24A5-4D69-9595-8A4B8FF84E86
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35004750-259EF442-24A5-4D69-9595-8A4B8FF84E86
Identification of potential surrogate end points in randomized clinical trials of aggressive and indolent non-Hodgkin's lymphoma: correlation of complete response, time-to-event and overall survival end points
P2860
Q35004750-259EF442-24A5-4D69-9595-8A4B8FF84E86
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35004750-259EF442-24A5-4D69-9595-8A4B8FF84E86
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
36a33dbca2047164ea4474c5d2d11f76d46474df
P2860
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL.